AnPac Bio-Medical Science Co., Ltd (ANPC): AnPac Bio-Medical Science Co., Ltd. is a...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

AnPac Bio-Medical Science Co., Ltd (ANPC)

Reply Private New

Keep Last Read

Next 10 Prev Next

ALERTS100%to10000%GAIN

Send PM Follow Ignore

Followers	1078
Posts	80316
Boards Moderated	8
Alias Born	03/10/2009

ALERTS100%to10000%GAIN

Re: None

Tuesday, 08/30/2022 7:53:34 AM

Tuesday, August 30, 2022 7:53:34 AM

AnPac Bio-Medical Science Co., Ltd. is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States.

STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent ANPC News

Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 12:03:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 08:23:50 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/02/2024 01:01:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2024 08:12:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2024 08:06:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2024 08:05:33 PM
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/25/2024 08:02:21 PM
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' • PR Newswire (US) • 05/19/2023 04:55:00 PM
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022 • PR Newswire (US) • 05/16/2023 09:00:00 PM
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results • PR Newswire (US) • 05/16/2023 08:15:00 PM
Fresh2 Reports Fiscal Year 2022 Annual Financial Results • PR Newswire (US) • 05/16/2023 08:15:00 PM

More ANPC News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow